This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Tue Jun 18, 2013 8:26 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Wed Apr 18, 2012 4:21 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1711
Image


Europe's drug regulator will likely allow Novartis AG's Gilenya to stay on the market without asking for much stricter safety warnings as it concludes a review of the multiple sclerosis pill initiated after reports of heart problems and the death of a patient who took the drug.

The regulator's decision could come as early as Thursday, said the London-based European Medicines Agency, the body responsible for licensing Gilenya in Europe a year ago.

The EMA launched the in-depth study in January to assess Gilenya's benefits and risks, and recommended doctors closely monitor the hearts of patients after they have been given the first dose of the drug.

The review was prompted by reports of heart problems in patients taking Gilenya, as well as the November death of a 59-year-old patient in the U.S. less than 24 hours after taking the first dose of the drug. The EMA had aimed to give an update on Gilenya's safety in March, but delayed its decision by about a month as it finalises its review... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Safety of oral MS pill Gilenya reviewed after deaths

squiffy2

0

1302

Tue Feb 28, 2012 4:49 am

squiffy2 View the latest post

There are no new unread posts for this topic. Novartis investigating death possibly linked to Gilenya

squiffy2

0

1155

Tue Dec 13, 2011 12:27 am

squiffy2 View the latest post

There are no new unread posts for this topic. Japan approves Novartis’ oral MS drug Gilenya

squiffy2

0

737

Wed Sep 28, 2011 1:09 am

squiffy2 View the latest post

There are no new unread posts for this topic. Rethink on MS pill Gilenya gives hope to Scots sufferers

squiffy2

0

563

Mon Sep 10, 2012 1:23 am

squiffy2 View the latest post

There are no new unread posts for this topic. Gilenya® shows long-term efficacy and safety - study

squiffy2

0

1009

Sun Jun 10, 2012 11:55 pm

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum